Avastin versus Lucentis

Ethical issues in treatment of age-related macular degeneration

Richard M. Klein, Ronnie Boriskin Klein

Research output: Contribution to journalEditorial

10 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1163-1165
Number of pages3
JournalRetina
Volume27
Issue number9
DOIs
StatePublished - Nov 2007
Externally publishedYes

Fingerprint

Clinical Ethics
Physician-Patient Relations
Choroidal Neovascularization
Angiogenesis Inhibitors
Macular Degeneration
Ethics
Vascular Endothelial Growth Factor A
Monoclonal Antibodies
Ranibizumab
Bevacizumab

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Avastin versus Lucentis : Ethical issues in treatment of age-related macular degeneration. / Klein, Richard M.; Klein, Ronnie Boriskin.

In: Retina, Vol. 27, No. 9, 11.2007, p. 1163-1165.

Research output: Contribution to journalEditorial

Klein, Richard M. ; Klein, Ronnie Boriskin. / Avastin versus Lucentis : Ethical issues in treatment of age-related macular degeneration. In: Retina. 2007 ; Vol. 27, No. 9. pp. 1163-1165.
@article{6c57639fdc4a4461813554a7f932ccdc,
title = "Avastin versus Lucentis: Ethical issues in treatment of age-related macular degeneration",
author = "Klein, {Richard M.} and Klein, {Ronnie Boriskin}",
year = "2007",
month = "11",
doi = "10.1097/IAE.0b013e31815e9322",
language = "English (US)",
volume = "27",
pages = "1163--1165",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Avastin versus Lucentis

T2 - Ethical issues in treatment of age-related macular degeneration

AU - Klein, Richard M.

AU - Klein, Ronnie Boriskin

PY - 2007/11

Y1 - 2007/11

UR - http://www.scopus.com/inward/record.url?scp=36749095193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36749095193&partnerID=8YFLogxK

U2 - 10.1097/IAE.0b013e31815e9322

DO - 10.1097/IAE.0b013e31815e9322

M3 - Editorial

VL - 27

SP - 1163

EP - 1165

JO - Retina

JF - Retina

SN - 0275-004X

IS - 9

ER -